Therapeutic effect of cimetidine in patients undergoing haemodialysis
- PMID: 435708
- PMCID: PMC1598296
- DOI: 10.1136/bmj.1.6164.650
Therapeutic effect of cimetidine in patients undergoing haemodialysis
Abstract
Blood concentrations of cimetidine were measured and the therapeutic effect of the drug assessed patients undergoing maintenance haemodialysis. Thirteen patients were given a single oral 200-mg dose of cimetidine a mean of 2.7 hours before the start of dialysis. Dialysing for 6--12-6 m2 hours led to a mean fall of 71% in blood cimetidine concentration during haemodialysis. Nine patients with various upper gastrointestinal lesions diagnosed endoscopically were treated for up to six weeks with a reduced cimetidine dose of 200 mg 12-hourly; two patients received two courses of treatment. Repeat endoscopy after treatment disclosed satisfactory healing, and the drug did not accumulate. This lower dose regimen is recommended for patients receiving dialysis who develop upper gastrointestinal lesions for which a histamine H2-receptor antagonist is indicated.
Similar articles
-
Cimetidine for duodenal ulceration in patients undergoing haemodialysis.Br Med J. 1977 Dec 10;2(6101):1506-8. doi: 10.1136/bmj.2.6101.1506. Br Med J. 1977. PMID: 589306 Free PMC article.
-
[Cimetidine in the treatment of peptic ulcer].Minerva Med. 1977 Oct 6;68(47):3277-82. Minerva Med. 1977. PMID: 335279 Clinical Trial. Italian.
-
Peptic ulcer disease following transplantation: the role of cimetidine.Am J Surg. 1982 Nov;144(5):545-8. doi: 10.1016/0002-9610(82)90577-3. Am J Surg. 1982. PMID: 6753618
-
Cimetidine 6 years later: a review.Can J Surg. 1983 Jul;26(4):312-5. Can J Surg. 1983. PMID: 6134575 Review.
-
[The therapeutic importance of cimetidine (Tagamet) (author's transl)].MMW Munch Med Wochenschr. 1978 Nov 3;120(44):1467-72. MMW Munch Med Wochenschr. 1978. PMID: 81467 Review. German.
Cited by
-
Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.Eur J Clin Pharmacol. 1982;21(4):325-30. doi: 10.1007/BF00637621. Eur J Clin Pharmacol. 1982. PMID: 7056278
-
Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.Eur J Clin Pharmacol. 1985;28(3):327-31. doi: 10.1007/BF00543332. Eur J Clin Pharmacol. 1985. PMID: 2861096
-
Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man.Eur J Clin Pharmacol. 1988;34(1):41-6. doi: 10.1007/BF01061415. Eur J Clin Pharmacol. 1988. PMID: 2896129
-
Clinical pharmacokinetics of cimetidine.Clin Pharmacokinet. 1983 Nov-Dec;8(6):463-95. doi: 10.2165/00003088-198308060-00001. Clin Pharmacokinet. 1983. PMID: 6418428 Review.
-
Prophylactic gastric operations in uremic patients prior to renal transplantation. Invited commentary.World J Surg. 1979 Aug 31;3(4):504. doi: 10.1007/BF01556119. World J Surg. 1979. PMID: 390895 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources